Insiders · Profile

Wilterding Mark

Chief Financial Officer at RxSight. Filing since 2 Sep 2026. CIK 0002107187

Company

Date

Role

Action

Shares

Amount

Of holding

RXST RxSight, Inc.

2 Sep 2026

Chief Financial Officer

Sold at will

7,765

$54.04K

23.7%

1 decision on file.